Drug intelligence / Profile preview

copper Cu 64 PSMA I&T

Development stage
Phase 3
Lead developer
Curium
Modality
Antibody-Radionuclide Conjugates → Antibody Conjugates → Antibody-Based Therapeutics
Administration
Intravenous
01

Overview

Copper Cu 64 PSMA I&T is a radiopharmaceutical diagnostic agent composed of a prostate-specific membrane antigen (PSMA)-targeting ligand (PSMA-I&T) linked to the chelator DOTAGA and labeled with the positron-emitting radioisotope copper-64. It is administered intravenously and used for positron emission tomography (PET) imaging to detect and localize metastatic or recurrent prostate cancer by targeting cells expressing PSMA, which is highly expressed in most prostate cancers. The agent enables high-sensitivity imaging due to the properties of copper-64, including its relatively long half-life, allowing centralized manufacturing and broad distribution. The drug is being developed primarily for use in PET/CT imaging for staging and detection of metastatic or recurrent prostate cancer[1][2][3][4][5].

Other names
copper Cu 64 PSMA I&TCopper Cu64 PSMA I&T
02

Targets

PSMA (Prostate-specific membrane antigen)

Beyond the preview

Go deeper on copper Cu 64 PSMA I&T.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Full profile access

Follow clinical development from study design and recruitment through results.

  • Trial phase
  • Status
  • Readouts

Indications & development

Full profile access

Explore development by indication, patient population, and geography.

  • Indications
  • Development status
  • Countries

Licensing & deals

Full profile access

Trace asset ownership, licensing agreements, and commercial partnerships.

  • Partners
  • Deal terms
  • Milestones

Patents & exclusivity

Full profile access

Explore the patent landscape and regulatory exclusivity around an asset.

  • Patents
  • Expiration dates
  • Exclusivity

Competitive landscape

Full profile access

Compare development programs by target, modality, and indication.

  • Competing assets
  • Targets
  • Development stage

Research & analysis

Full profile access

Connect source evidence and development news to your research questions.

  • Publications
  • News
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on copper Cu 64 PSMA I&T.

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call